Ligand profile
JW5
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: HT085_RS00140 — orotate phosphoribosyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
JW5- PDB
2qcm- UniProt (similar protein)
P11172- Target protein
- HT085_RS00140
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 191.5
- −1 ≤ LogP ≤ 5 -3.24
- MW ≤ 500 Da 354.2
- LogP ≤ 5 -3.24
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 191.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)COC1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)CO
InChI=1S/C10H15N2O10P/c13-2-4-1-6(14)11-10(17)12(4)9-8(16)7(15)5(22-9)3-21-23(18,19)20/h1,5,7-9,13,15-16H,2-3H2,(H,11,14,17)(H2,18,19,20)/t5-,7-,8-,9-/m1/s1InChI=1S/C10H15N2O10P/c13-2-4-1-6(14)11-10(17)12(4)9-8(16)7(15)5(22-9)3-21-23(18,19)20/h1,5,7-9,13,15-16H,2-3H2,(H,11,14,17)(H2,18,19,20)/t5-,7-,8-,9-/m1/s1
MSQUFEPNTQRBDI-ZOQUXTDFSA-NMSQUFEPNTQRBDI-ZOQUXTDFSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00215
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand JW5 →
- PDB RCSB structure 2qcm →
- UniProt UniProt P11172 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “JW5”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00140.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).